Transient vision loss is a temporary episode where vision partially or completely disappears in one or both eyes, then returns on its own. Episodes can last anywhere from a few seconds to an hour, and the cause ranges from relatively harmless (like a migraine) to potentially dangerous (like a blood clot traveling from a narrowed artery). The distinction matters because some causes carry a meaningful stroke risk: one large study found that patients with transient monocular blindness from arterial disease had a 10% chance of stroke within three years.
One Eye vs. Both Eyes
The single most important detail about a transient vision loss episode is whether it affected one eye or both. This isn’t always obvious in the moment, but it points doctors toward very different parts of the visual system.
Loss in one eye (monocular) is the more common type. It typically means something disrupted blood flow to the retina, the optic nerve, or the layer of tissue behind the retina in that eye. The most frequent culprit is disease in the carotid artery on the same side of the neck, where fatty buildup or a tear in the artery wall sends small clots downstream into the eye’s blood supply.
Loss in both eyes (binocular) is less common and points to a problem further back in the visual pathway, often in the brain itself. Migraine aura, seizures, and reduced blood flow through the arteries at the base of the skull can all cause it. Because both eyes share visual processing areas in the brain, anything affecting those regions produces symptoms in both eyes simultaneously.
Vascular Causes
Blood flow problems are the leading cause of transient vision loss, and they deserve the most attention because they can signal serious cardiovascular disease.
Carotid artery disease. Cholesterol plaques or tears in the carotid artery can release tiny clots that temporarily block the central retinal artery or one of its branches. This produces sudden, painless vision loss in one eye, often described as a dark curtain or shade dropping over the field of view. These episodes typically last 1 to 4 minutes before vision returns as the clot dissolves or moves on.
Heart-related emboli. Clots can also originate in the heart itself, particularly in people with irregular heart rhythms, valve disease, or, more rarely, benign heart tumors. These clots travel through the bloodstream and can lodge briefly in the arteries feeding the eye.
Giant cell arteritis (GCA). This is an inflammatory condition that affects medium and large arteries, most often in people over 50. It causes the artery walls to swell, which chokes off blood supply to the optic nerve. GCA is especially concerning because without treatment, it can progress to permanent vision loss. Common accompanying symptoms include a new headache, scalp tenderness, jaw pain while chewing, and morning stiffness in the shoulders or neck. Blood tests typically show elevated inflammation markers. If GCA is suspected, doctors treat it urgently.
Vertebrobasilar insufficiency. The vertebral and basilar arteries supply the back of the brain, where visual processing happens. Reduced flow through these arteries can cause vision loss in both eyes, sometimes accompanied by dizziness or difficulty with balance.
Non-Vascular Causes
Not every episode of transient vision loss points to a blood vessel problem. Several neurological and eye-related conditions can produce similar symptoms.
Migraine. Visual migraine aura is one of the most common non-vascular causes. It often produces shimmering lights, zigzag lines, or blind spots that expand or drift across the visual field over 20 to 60 minutes. A visual disturbance that lasts less than 20 minutes or more than 60 minutes, or one that appears suddenly without any expansion or migration, is less likely to be migraine and warrants further investigation. Migraine aura can occur without any headache at all, which sometimes makes it harder to recognize.
Papilledema. When pressure inside the skull rises, it can cause swelling of the optic discs at the back of both eyes. This produces brief episodes called transient visual obscurations, where vision goes blurry, gray, or black for about 5 to 15 seconds, often triggered by a change in posture like standing up. Causes of elevated skull pressure include brain tumors, blood clots in the brain’s drainage veins, and a condition called idiopathic intracranial hypertension.
Other eye conditions. Intermittent angle-closure glaucoma (a sudden spike in eye pressure) and optic disc drusen (calcium deposits on the optic nerve) can both produce brief visual disturbances that resolve on their own.
What Different Episodes Feel Like
The character of the vision loss offers clues about its cause. Ischemic episodes from carotid disease tend to feel like a shade being pulled down or up over one eye. The onset is sudden and painless, and the episode resolves within a few minutes. People sometimes describe it as their eye “going dark.”
Migraine-related vision loss behaves differently. It usually involves positive visual phenomena, meaning you see something abnormal (flashing lights, shimmering arcs) rather than just losing vision. The disturbance builds gradually and moves across the visual field. It affects both eyes, though people sometimes mistakenly think only one eye is involved.
Papilledema-related obscurations are the briefest, lasting only seconds. They are closely tied to posture changes and often affect both eyes. If you notice your vision graying out every time you stand up or bend over, this pattern is worth mentioning to a doctor.
Why It Matters for Stroke Risk
Transient monocular vision loss caused by carotid artery disease is essentially a warning stroke (sometimes called a transient ischemic attack, or TIA) affecting the eye instead of the brain. The same clot that temporarily blocked vision in the retina could next travel to the brain and cause a full stroke. Data from the North American Symptomatic Carotid Endarterectomy Trial found that 1 in 10 patients who experienced this type of transient blindness went on to have a stroke within three years if the underlying carotid disease went untreated.
This is why any sudden, painless loss of vision in one eye is treated as an urgent medical situation, even if vision returns completely. The episode itself may be harmless, but what it signals about the blood vessels can be critical.
How Doctors Evaluate It
The evaluation starts with a detailed description of the episode: which eye was affected (or both), how long it lasted, what the vision loss looked like, whether it was painful, and what you were doing when it started. These details narrow the list of possible causes significantly.
For suspected vascular causes, imaging of the carotid arteries (usually with ultrasound) and the heart (with echocardiography) helps identify the source of potential clots. Blood tests measuring inflammation markers help screen for giant cell arteritis, particularly in patients over 50 with headache or scalp tenderness. An ESR (a measure of how quickly red blood cells settle in a tube) above 50 millimeters per hour is one of the key findings that raises suspicion for GCA.
If the vision loss affected both eyes and the pattern doesn’t fit migraine, brain imaging with MRI may be ordered to look for problems in the visual processing areas. An EEG, which records the brain’s electrical activity, may be used if seizures are a possibility.
A thorough eye exam is also part of the workup. Doctors look at the retina and optic nerve for signs of swelling, deposits, or evidence of past blood flow interruptions that might not have caused noticeable symptoms.
Treatment Depends on the Cause
There is no single treatment for transient vision loss because it is a symptom, not a disease. What matters is identifying and addressing the underlying cause.
For carotid artery disease, treatment focuses on preventing future clots. This may involve blood-thinning medications, cholesterol-lowering drugs, and management of risk factors like high blood pressure and smoking. In cases where the artery is severely narrowed, a procedure to open or bypass the blockage may be recommended.
For giant cell arteritis, high-dose anti-inflammatory treatment is started immediately, often before biopsy results come back, because the risk of permanent vision loss is high if treatment is delayed.
For migraine-related vision loss, the approach is the same as managing migraine more broadly: identifying triggers, making lifestyle adjustments, and sometimes using preventive medications if episodes are frequent or prolonged.
For papilledema, the priority is reducing the elevated pressure inside the skull, which depends on identifying what’s causing it. Once the pressure normalizes, the visual obscurations typically stop.